Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Regulatory Disorder”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableStudy completedNCT00521508
What this trial is testing

Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Centre Hospitalier Universitaire de Saint Etienne 45
Testing effectiveness (Phase 2)Looking for participantsNCT06747312
What this trial is testing

Effect of Belimumab on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Early research (Phase 1)Ended earlyNCT00376519
What this trial is testing

Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Masonic Cancer Center, University of Minnesota 3
Not applicableNot Yet RecruitingNCT07067112
What this trial is testing

Suppressive Functions of Regulatory T Cells in Migraine

Who this might be right for
Chronic Migraine
University Hospital, Clermont-Ferrand 24
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT05787574
What this trial is testing

Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

Who this might be right for
Primary Immune Regulatory DisorderAutoimmune LymphoproliferativeImmune System Diseases
Memorial Sloan Kettering Cancer Center 39
Not applicableLooking for participantsNCT06426316
What this trial is testing

The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.

Who this might be right for
Migraine DisordersPainAutoimmune Diseases+5 more
University Hospital, Clermont-Ferrand 396
Testing effectiveness (Phase 2)Study completedNCT06315530
What this trial is testing

Effect of Telitacicept on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07284641
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Who this might be right for
Common Variable Immunodeficiency (CVID)Primary Immune Regulatory DisorderImmune Dysregulation+12 more
Paul Szabolcs 25
Not applicableUnknownNCT05677724
What this trial is testing

Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment

Who this might be right for
HBVPrimary Liver Cancer
Fubing Wang 20
Early research (Phase 1)WithdrawnNCT02526329
What this trial is testing

Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant

Who this might be right for
Graft Versus Host Disease
Everett Meyer
Testing effectiveness (Phase 2)Looking for participantsNCT06839456
What this trial is testing

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Who this might be right for
LeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more
Children's Hospital of Philadelphia 100